- Home
- EMD vs YDES Comparison
EMD vs YDES Comparison
Compare EMD & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | EMD | YDES |
|---|---|---|
| Founded | 2003 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 626.6M | 543.0M |
| IPO Year | 2003 | N/A |
Fundamental Metrics
Financial Performance| Metric | EMD | YDES |
|---|---|---|
| Price | $10.52 | $2.53 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 169.3K | 34.7K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | ★ 10.25% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.60 | $1.70 |
| 52 Week High | $11.30 | $25.00 |
Technical Indicators
Market Signals| Indicator | EMD | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 44.14 | 48.98 |
| Support Level | $10.47 | $1.93 |
| Resistance Level | $10.61 | $2.93 |
| Average True Range (ATR) | 0.12 | 0.32 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 25.00 | 48.84 |
Price Performance
Historical ComparisonAbout EMD Western Asset Emerging Markets Debt Fund Inc
Western Asset Emg Markets Debt Fund Inc is a non-diversified closed-end management and long term investment company. The primary investment objective of the company is to seek high current income, and the secondary objective is to seek capital appreciation.
About YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.